Bristol-Myers Squibb Company (BMY)

74.98
+0.54(+0.72%)
  • Volume:
    1,608,172
  • Day's Range:
    74.39 - 75.18
  • 52 wk Range:
    65.00 - 81.43

BMY Overview

Prev. Close
74.45
Day's Range
74.39-75.18
Revenue
46.74B
Open
74.44
52 wk Range
65-81.43
EPS
3.1
Volume
1,608,172
Market Cap
166.03B
Dividend (Yield)
2.28
(3.06%)
Average Volume (3m)
8,870,929
P/E Ratio
24.14
Beta
0.392
1-Year Change
14.56%
Shares Outstanding
2,219,644,935
Next Earnings Date
Apr 27, 2023
What is your sentiment on Bristol-Myers Squibb?
or
Vote to see community's results!

Bristol-Myers Squibb Company News

Bristol-Myers Squibb Company Analysis

Bristol-Myers Squibb Company Company Profile

Bristol-Myers Squibb Company Company Profile

Employees
32200

Bristol-Myers Squibb Company is a biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of biopharmaceutical products. It offers products for a range of therapeutic classes, which include oncology, immunology, cardiovascular and fibrosis. Its pharmaceutical products include chemically synthesized or small molecule drugs and products produced from biological processes, called biologics. Biologics are administered to patients through injections or by infusion. Its products include Revlimid, Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Sprycel, Yervoy, Abraxane, Empliciti, Reblozyl, Inrebic, Onureg, Zeposia, Vidaza, Baraclude and Breyanzi. It also has a pipeline of investigational medicines designed to target the common mutations associated with oncogenesis, including repotrectinib. Its products are sold to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies.

Read More

Analyst Price Target

Average82.22 (+10.00% Upside)
High95.00
Low62.00
Price74.74
No. of Analysts18
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyStrong BuyStrong BuyBuy
Technical IndicatorsBuyStrong BuyStrong BuyStrong BuyStrong Buy
SummaryBuyStrong BuyStrong BuyStrong BuyStrong Buy
  • what do you guys say about this stock ? good opportunity? or not
    0
    • long term yes, couple years this stock will be close to $90
      0